MUCUS RELIEF- guaifenesin tablet 
Geri-Care Pharmaceuticals, Corp

----------

gc 714

Active ingredient (in each caplet)

Guaifenesin 400 mg

Purpose

Expectorant

Uses

helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive to rid the bronchial passageways
of bothersome mucus

Warnings

Ask a doctor before use if you have

Stop use and ask a doctor if

If pregnant or breast feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

adults and children 12 years
of age and over
• take 1 caplet, every 4 hours,
while symptoms persist • do
not exceed 6 doses in 24 hours
children under 12 years of agedo not use

Other information

• Tamper Evident: do not use if imprinted safety seal under cap is broken or missing.

• store at room temperature 15°-30°C (59°-86°F)

Inactive ingredients

cellulose, magnesium stearate, maltodextrin, povidone, silica, stearic acid.

Questions or comments?

1-800-540-3765

package Label

1

MUCUS RELIEF 
guaifenesin tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:57896-714
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN400 mg
Inactive Ingredients
Ingredient NameStrength
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
POVIDONE (UNII: FZ989GH94E)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
Product Characteristics
ColorwhiteScore2 pieces
ShapeOVALSize17mm
FlavorImprint Code AP;152
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:57896-714-01100 in 1 BOTTLE; Type 0: Not a Combination Product02/01/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01202/01/2021
Labeler - Geri-Care Pharmaceuticals, Corp (611196254)
Registrant - Geri-Care Pharmaceuticals, Corp (611196254)

Revised: 10/2023
Document Id: 088ce4aa-e0dd-6372-e063-6294a90ac941
Set id: c5ea5a7a-c806-e5e0-e053-2995a90a15e9
Version: 2
Effective Time: 20231025
 
Geri-Care Pharmaceuticals, Corp